From: Lymphoepithelioma-like carcinoma of the urinary bladder: a case report and review of the literature
Features | Group 1- Pure | Group 2- Predominant | Group 3- Focal |
---|---|---|---|
Number of patients | 39 (49%) | 26 (34%) | 13 (17%) |
Male | 21 | 14 | 11 |
Female | 2 | 12 | 2 |
NA | 16 | - | - |
Age | |||
Mean | 67.8 | 72.7 | 71.6 |
Range | 52-81 | 55-90 | 58-84 |
Stage | |||
T1 | 7 (18%) | 1 (3%) | 2 (15%) |
T2 | 21 (54%) | 16 (62%) | 7 (54%) |
T3 | 8 (22%) | 9 (35%) | 4 (31%) |
T4 | 2 (6%) | - | - |
Primary treatment | |||
TURBT | 23 (59%) | 14 (54%) | 7 (54%) |
Partial cystectomy | 2 (5%) | 2 (8%) | - |
Radical cystectomy | 14 (36%) | 10 (38%) | 6 (46%) |
Adjuvant treatment | |||
Systemic chemotherapy | 15 (38%) | 3 (12%) | 1 (8%) |
Radiotherapy | 6 (16%) | 5 (19%) | 3 (23%) |
Chemoradiotherapy | 2 (5%) | 1 (4%) | 1 (8%) |
Intravesical chemotherapy | 3 (8%) | - | - |
Not performed | 13 (33%) | 17 (65%) | 8 (61%) |
Follow-up | |||
Mean | 35.2 | 30.1 | 30.6 |
Range | 2-216 | 2-104 | 0-84 |
Outcome | |||
Not evidence of disease (NED) | 31 (81%) | 20 (84%) | 1 (8%) |
Died of disease (DOD) | 1 (3%) | 1 (4%) | 11 (84%) |
Died without disease (DWD) | 5 (13%) | 2 (8%) | 1 (8%) |
Alive with metastases (AWM) | 1 (3%) | 1 (4%) | - |
Cause-specific survival rate | 97% | 95% | 15% |